<DOC>
	<DOCNO>NCT01602471</DOCNO>
	<brief_summary>This trial first trial Investigation Product ( IP ) , [ F-18 ] RGD-K5 carotid plaque image conduct Phase II trial since compound already test human phase I phase II imaging . All study result evaluate analyzed order consider design future clinical trial .</brief_summary>
	<brief_title>F-18 RGD-K5 Positron Emission Tomography ( PET ) Participants With Carotid Artery Stenosis</brief_title>
	<detailed_description>This investigation conduct Phase II , open-label , single-center , non-randomized study . The study plan conduct one Investigative site United States . The information collect exploratory , Phase II study use diagnostic purpose , ass participant 's response therapy , clinical management participant . This pilot prospective cohort study increase expression integrin may see F-18 RGD-K5 PET image scan look carotid plaque participant carotid artery stenosis . Each complete study participant undergo one three visit , include one eligibility study visit , Computed Tomography ( CT ) angiogram carotid visit ( necessary ) , [ F-18 ] RGD-K5 PET image visit , 24 hour follow phone call visit . Procedures : Informed consent ( ICF ) , eligibility blood lab , collection demographic information medical history , physical examination , vital sign , 12-lead Electrocardiograms ( ECGs ) , dose [ F-18 ] RGD-K5 , PET image scan , 24 hour follow collect adverse event , plaque immunohistochemical characterization Carotid Endarterectomy ( CEA ) .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>Participant female male race / ethnicity &gt; 18 year old time investigational product administration Participant participant 's legally acceptable representative provide write informed consent Participant capable comply study procedure Participant know carotid artery stenosis &gt; 69 % luminal diameter base carotid ultrasound deem surgical candidate endarterectomy determine vascular surgeon Participant carotid ultrasound report available collection Participant schedule carotid CT angiogram plaque localization within 30 day sign ICF ( else schedule Carotid CT angiogram ) CTA must perform separate day prior investigational PET procedure ) Participant consent endarterectomy Participant schedule investigational [ F18 ] RGDK5 PET/CT scan within 4 week prior endarterectomy Participant must renal function value define laboratory result within follow range : Serum creatinine ≤ 1.5 mg/dL Estimated glomerular filtration rate ( eGFR ) ≥ 45mL/min Participant nursing Participant pregnant Participant involve investigative , radioactive research procedure within past 14 day Participant condition personal circumstance , judgment investigator , might interfere collection complete data data quality Participant history current evidence condition , therapy , lab abnormality , opinion study investigator treat physician might confound result study pose additional risk participant participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Endarterectomy</keyword>
	<keyword>K5-C200</keyword>
	<keyword>RGD-K5</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>Carotid CT Angiogram</keyword>
</DOC>